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REGIONAL VARIATIQ IW bWCARDIAL ACCUMULATI0N of 
~~FLUORODEOXYGLUC~SE IN FASTED NORMAL SUBJECTS. 
R.J. Groplsr, M.D., K.J. lee, W.B., B.S. 
h D B A >qegel, H.D., E.M. GelQnan, 
Ua;h;~Bt~n'Unfversftyr St.Louis, 
Post tron emission taography utflf ring 18Wluomdeo%y- 
glucose (FDG) has been used for identifying jeopardized 
but viable oprocardfutn. It has been asswaed that the re- 
alma1 distribution of FD6 accumulation (FDGA) in the _.- _ - 
';&& heart is relatively haaogeneous and independent of 
levels of circulating substrates. 
studies of fasted nonnal humans observed large re- 
gfonal disparities in qyocardfal FD6-A. Acco 
fonal qyocardlal glycoly 
t to region 1 f perfusion tabolfsrn tI C-acetate (A 
died after a S-hour fast and 5 s 
fasted and fed. Septunkto-lateral wall ratios (SLR; wean 
f SD) were detellained for FDG-A, AC accumulation (AC-A) 
and clearance (AC-C), and NF. rider fasting conditions 
regional disparities in FDG-A re noted (SLR of J2 * 
.ll), that dflalnfshed significantly with feeding (SLR of 
.90 ti 48, p < .OS). With fasting, F, AC-A and AC-C 
were holnogeneous (SLR 8 f .07, .9 t .09, 
respectively; p < .OS 
and did not change si 
(SLR of 1.1 t .3, 1.1 
Thus, under fasting c 
regional variations 1
are independent of ox 
which cannot be attrf 
(since AC accuRu1 atfon 
reafonal dfsuarftfes in F 
t&s st bi considered in analysis of data so-acqufwd. 
ATTENUATED RESPONSE OF G TABO~ISM IN 
REPERFUSED CANINE MYOCA CHANGES IN 
SUBSTRATE LEVELS. 
Denis B. Buxton, Ph.D.. Janine 
rben A. Hansen B.Sc Carl E 
M.D., F.A.C.C. tiC!LA’;chool oi 
Medicine, Los Angeles, CA. 
Fluoro-2-cleoxyglucose (FDG) is used with PET to measure ngional 
glucose utilization and to study altered glucose metabolism in ischemic 
injury. However. rhe effects of substrate availabililv on these . 
m-ti&nents ha& not been s~smatidl~ &mined. In iOcloscd 
chest dogs, the proximal LAlj was occl&d with an intmcoronary 
balloon for 20 min. On day 2.5 dogs were maintained at steady state 
euglycemic (EUG) levels (12SilO mg/dl) and 5 dogs at hyperglycemic 
(HYPG) levels (184ti.6 mgldl). FDG was injected and the arterial 
input function obtained. Microsphere blood flow was measurul during 
occlusion and prior to FIX. Wall motion by echocardiography was 
abnormal in all 10 dogs 30 min after repetfusion (stunning) and in 8 of 
10 dogs prior to FDG. ‘lTC staining of reperfused myocardium (RM) 
revtaled subendocardial necrosis in 1 dog and speckled anterior 
i 
apallary muscle necrosis in 3 dogs. Tissue m activity in control and 
Mwas convenedtomctabolicrate(MR,mg/min/lOOgm). Occlusion 
blood flows were similar in HYPG and EUG dogs in conaol(l.7&Q.6 
vs 1,4fo.S ml/min/gm; NS) and RM (O.Sti.48 vs 0.38fO.25 
ml/muVgm; NS). MR in HYPG dogs was 4-6 fold higher than in EUG 
dogs in control (SO.Sf23.1 vs 8.9f6.4; p<o.OOS) and RM (37.til9.4 
vs 11.4*7.; @.OZS). Relative tocontrol tissue, MR in RM was 
S8f58% higher in EUG dogs but 24fl7% lower in HYPG dogs 
(~~0.01). Thus, glucose utilizakn i nperfused myocardium is 
elmed during euglycemia, but increases dispqoreionately less than in 
con~l myocardium in HYPG, The results are consistent with altend 
gkose metabolism inRMwhich&pcndslt~thanthanmyocardium 
on subsaate availability. They also indicate that metabolic evalution of 
RM requires knowledge of substrate levels. 
